A guide to vaccinations for COVID-19: references
Reference list for 'A guide to vaccinations for COVID-19'
- University of Oxford, Vaccine Knowledge Project Herd immunity (updated: September 2023)
- UK Health Security Agency 2023 Greenbook chapter 14a COVID-19 (published 4 September 2023)
- UK Health Security Agency 2023 Guide to the use of human and animal products in vaccines (updated 13 March 2023)
- UK Health Security Agency 2022 The effectiveness of vaccination against long COVID (published 12 January 2022)
- University of Oxford, Vaccine Knowledge Project How vaccines are tested, licensed and monitored (updated 17 August 2023)
- Victoria Male 2021 Are COVID-19 vaccines safe in pregnancy? Nature Reviews Immunology DOI: 10.1038/s41577-021-00525-y
- Zace et al. 2022 The impact of COVID-19 vaccines on fertility – A systematic review and meta-analysis Vaccine DOI: 10.1016/j.vaccine.2022.09.019
- Victoria Male Explainer on COVID vaccination, fertility, pregnancy and breastfeeding (updated 3 October 2023)
- Pardi et al. 2018 mRNA vaccines – a new era in vaccinology Nature Reviews Drug Discovery DOI 10.1038/nrd.2017.243
- Polack et al. 2020 Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine New England Journal of Medicine DOI: 10.1056/NEJMoa2034577
- UK Health Security Agency 2022 How well do vaccines protect against Omicron? What the data shows (published 10 February 2022)
- NHS 2022 Pregnancy, breastfeeding, fertility and COVID-19 vaccination (updated 24 October 2022)
- Allotey et al. 2020 Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis The British Medical Journal DOI: 10.1136/bmj.m3320
- Baden et al. 2020 Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine New England Journal of Medicine DOI: 10.1056/NEJMoa2035389
- Medicines & Healthcare products Regulatory Agency 2023 Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection (updated 20 April 2023)
- UK Health Security Agency 2023 Guide to the use of human and animal products in vaccines (updated 13 March 2023)
- De Bruyn et al. 2023 Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study eClinical Medicine DOI: 10.1016/j.eclinm.2023.102109
- Kirsebom et al. 2023 Effectiveness of the adjuvanted Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation amongst adults aged 75 years and older in England, estimated using a test-negative case control study design preprint medRxiv DOI: 10.1101/2023.09.28.23296290
- Novavax Our Matrix-M™ adjuvant technology (accessed 23 October 2023)
- Sharma et al. 2023 Saponins: A concise review on food related aspects, applications and health implications Food Chemistry Advances DOI: 10.1016/j.focha.2023.100191
- Heath et al. 2021 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine New England Journal of Medicine DOI: 10.1056/nejmoa2107659
- Johnson & Johnson 2020 Johnson & Johnson announces European Commission approval for Janssen’s preventive Ebola vaccine (accessed 23 October 2023)
- University of Oxford, Oxford Vaccine Group Vaccines against Ebola virus disease (published 19 June 2019)
- Voysey et al. 2021 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK The Lancet DOI: 10.1016/S0140-6736(20)32661-1